Shimadzu Corporation (SHMXY) Fair Value & Analysis
Technology · US · Market cap $6.4B
Shimadzu Corporation
SHMXY · US
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 6 days ago
Share price −6.4% over the past month.
Price vs Fair Value (12 months)
12‑month range $10.41 – $16.77 · fair‑value band $8.64 – $19.87 · the $11.05 price screens below the $13.67 fair value. As of Jun 24, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
Shimadzu Corporation (SHMXY) currently trades at $11.05, while our model-based Fair Value estimate is $13.67 — implying the stock looks roughly 23.7% undervalued today. We read business quality at 91/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Shimadzu Corporation generated revenue of $561B at a net margin of 10.8%. Revenue grew 4.7% year over year. It earns a return on equity of 11.4%. The stock trades on a trailing P/E of 17.0. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Shimadzu Corporation provides equipment solutions in Japan and Internationally. It operates through Measuring Instruments, Medical Equipment, Industrial Equipment, and Aircraft Equipment business segments. The company offers analytical and measuring instruments which includes gas and liquid chromatography, gas and liquid chromatograph-mass spectrometry, software and informatics, molecular spectroscopy, elemental analysis, surface analysis, life science lab instrument, material testing, non-destructive testing, total organic carbon analysis, continuous monitoring analysis, thermal analysis, particle size analysis, and balance products, as well as MALDI-based instruments and solutions, columns, reagents, and consumables products. It also provides medical systems comprising angiography, fluoroscopy, mobile C-arm, radiography, mobile X-ray systems, PET, and fluorescence imaging products; optical devices which consist of diffraction gratings, aspherical mirrors, laser mirrors and windows…
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Shimadzu Corporation reported revenue of $539B in FY2025 versus $428B in FY2022, a compound +8.0%/yr. Reported net income was $53.8B in FY2025, compounding +4.4%/yr from FY2022.
Open the full interactive analysis →
Similar stocks
6 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Keyence Corporation KYCCF | $457.38 | $228.86 | -50% |
| Keysight Technologies, Inc KEYS | $324.00 | $92.23 | -72% |
| Garmin Ltd GRMN | $231.72 | $186.06 | -20% |
| Chroma ATE Inc 2360 | 2,565 TWD | 359.43 TWD | -86% |
| Teledyne Technologies Incorporated TDY | $602.27 | $358.39 | -40% |
| Hexagon AB HXGBF | $8.37 | $5.49 | -34% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Shimadzu Corporation (SHMXY) undervalued?
What is the fair value of SHMXY?
What is the quality score of SHMXY?
What is the revenue of Shimadzu Corporation (SHMXY)?
What is the net profit margin of SHMXY?
Does Shimadzu Corporation pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.